Katharine Thomas is an Oncology physician affiliated with University of Nevada. OpenAlex indexes 80 publications with 2,187 citations (h-index 15).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
75 Pringle Way Ste 801
Reno, NV 895028400
Telephone
775-982-5000Provider last certified this registry record 22 Jul 2022.
Industry payments
40 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Exelixis Inc.Program year202590 payments$47,731openpaymentsdata.cms.gov ↗
- Novartis Pharmaceuticals CorporationProgram year20251 payment
- Daiichi Sankyo Inc.Program year202511 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
25.8%Serotonin-3 Receptor Antagonist15.4%Ondansetron Hcl100%Part D≥41 patientsCorticosteroid10.4%Prednisone100%Part D≥15 patientsCancer & immunology
23.8%Cytochrome P450 17A1 Inhibitor8.9%Abiraterone Acetate100%Part D<11 patientsAromatase Inhibitor4.2%Anastrozole100%Part D<11 patients+ 3 more classes in this area
Nervous system
22.2%Phenothiazine16.7%Prochlorperazine Maleate100%Part D≥45 patientsOpioid Agonist5.5%Oxycodone Hcl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Current and emerging strategies for the management of advanced/metastatic lung neuroendocrine tumors
Current Problems in Cancer
2024 - The Role of Coronary Blood Flow and Myocardial Edema in the Pathophysiology of Takotsubo Syndrome
JACC. Cardiovascular imaging
2024 - Comparison of T1- and t2-mapping in the Detection of Acute Myocardial Oedema in Takotsubo Syndrome
Journal of Cardiovascular Magnetic Resonance
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Buddhadeb Dawn, MD
University of Nevada
Paul Hauptman, MD
University of Nevada
Lali Sekhon, MD, PhD
University of Nevada
Abraham Rothman, MD
University of Nevada
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”